GlassScriptPhysician profile
Ian Farah
NPI 1689641011
$1,364.37
in general payments reported to CMS, 2019-2025
11 companies · $176 in 2025
The $176 reported for 2025 was more than what 87% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $418 · 2022: $402 · 2023: $193 · 2024: $175 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $414.84 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $230.20 | 2021-2024 | Exparel |
| Becton, Dickinson and Company | $159.53 | 2025 | Hemosphere |
| Merck Sharp & Dohme LLC | $128.58 | 2022-2025 | Bridion |
| Acacia Pharma INC | $103.53 | 2021-2022 | |
| Masimo Corporation | $101.74 | 2021-2023 | Set and Rainbow Set |
| Trevena, INC. | $99.99 | 2021 | |
| Ge Healthcare | $55.32 | 2023 | |
| Edwards Lifesciences Corporation | $34.20 | 2021-2024 | Hemosphere |
| Haemonetics Corporation | $18.27 | 2023 | Teg6s Hemostasis System |
| Acera Surgical, INC. | $18.17 | 2024 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Farah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.